Our Mission
Our mission is to prevent cardiovascular disease using AI-driven early warning and real-time monitoring, enabling earlier risk detection and a transition from reactive treatment to proactive, affordable care.
Our Guiding Principles
The foundation behind every decision we make.
Our Vision
To redefine cardiovascular care, setting continuous monitoring, early warning, and personalized prevention as the global standard—
creating a smart health platform that advances medical innovation and makes reliable heart health accessible to all.
Our Milestones
← PREV
NEXT →
2016
- Company Established
2019
- NMPA (CFDA) Certification Achieved
2022
- TFDA Certification Achieved
2025
- New headquarter set up atTai Yuen Hi-Tech Industrial Park
- FDA 510K K243003
- ISO1348
2026
- Obtain FDA SaMD approval
- Obtain medical regulatory approvals in ASEAN, South America, and Middle Eastern countries.
- Apply for MDA
- Home
- About
- Product
- Support
Taiwan Headquarters
6F-1, No. 12, Taiyuan 2nd St., Zhubei City, Hsinchu County, Taiwan
Phone: +886 3 668 2091
Email: sales@vsigntek.com
US Branch Office
46540 Fremont Blvd Ste 514, Fremont, CA 94538
Phone: +1 (510) 490-7899
Email: sales@vitalsignscorp.com
